The Patent Finder
PB

Prognosys Biosciences, Inc.

First filing 2011
OverviewNotableFeesChangesFamiliesPatent listSources & methods

76 patents currently held

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Apr 2030. from the record

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
15
Ending by 2030
Apr 2030
Next term end
8
Patent families

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
notable patents all others Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
System for Analyzing Targets of a Tissue Section US 11,542,543
Cited by 188 later US patents, top 1% of utility patents granted in 2023 in our data. Protection runs to 2031. A terminal disclaimer caps this term to an earlier patent's.
Ends Apr 2031 · High confidence
Also notable
Methods and Systems for Determining Spatial Patterns of Biological Targets in a Sample US 11,286,515
Cited by 259 later US patents, top 1% of utility patents granted in 2022 in our data. Protection runs to 2034. A terminal disclaimer caps this term to an earlier patent's.
Ends Jun 2034 · High confidence
Also notable
Nucleic Acid Constructs and Methods of Use US 9,085,798
The most cited patent in this portfolio, cited by 771 later US patents, top 1% of utility patents granted in 2015 in our data. Protection runs to 2030.
Ends Aug 2030 · High confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 21, 2027
    The maintenance fee for Nucleic Acid Constructs and Methods of Use (US 9,085,798) comes due Jan 21, 2027. Unpaid by Jul 21, 2027, it lapses early.
  • 2 fees due Feb 22, 2027
  • 3 fees due Mar 12 to 26, 2027 · next Mar 12
  • 3 fees due May 12 to 21, 2027 · next May 12
  • 2 fees due Jun 3 to 10, 2027 · next Jun 3
  • 1 fee due Jul 9, 2027
    The maintenance fee for Spatially Encoded Biological Assays (US 11,866,770) comes due Jul 9, 2027. Unpaid by Jan 10, 2028, it lapses early.
  • 1 fee due Aug 27, 2027
    The maintenance fee for Methods for Detecting Peptide/Mhc/Tcr Binding (US 11,913,952) comes due Aug 27, 2027. Unpaid by Feb 28, 2028, it lapses early.
  • 2 fees due Oct 7 to 14, 2027 · next Oct 7

Which patents, and when each one lapses · Pro

Recent changes

  • 2 of the patents on this record were granted since Aug 23, 2026

What they patent

The largest of its 8 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 9,783,847Nucleic Acid Constructs and Methods of Use
In force
 · High confidence
In forceHigh confidence
US 10,000,800Nucleic Acid Constructs and Methods of Use
In force
 · High confidence
In forceHigh confidence
US 10,119,165Nucleic Acid Constructs and Methods of Use
In force
 · High confidence
In forceHigh confidence
US 10,266,883Nucleic Acid Constructs and Methods of Use
In force
 · High confidence
In forceHigh confidence
US 10,266,884Nucleic Acid Constructs and Methods of Use
In force
 · High confidence
In forceHigh confidence
US 11,339,432Nucleic Acid Constructs and Methods of Use
In force
 · High confidence
In forceHigh confidence
US 11,352,665Nucleic Acid Constructs and Methods of Use
In force
 · High confidence
In forceHigh confidence
US 9,085,798Nucleic Acid Constructs and Methods of Use
In force
 · High confidence
In forceHigh confidence
US 10,501,793Nucleic Acid Constructs and Methods of Use
In force
 · High confidence
In forceHigh confidence
US 12,234,505Spatially Encoded Biological Assays
In force
 · High confidence
In forceHigh confidence
10 of 76 patents shown.
Pro members see all 76.
Pro members: see all 76 patents
Also on record, not counted in the 76: 12 applications pending · 17 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited